価格表

在庫・価格 : 2024年04月28日 07時28分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Methylcellulose Complete Media w/o Epo, for Human
データシート※最新のデータシートでない場合があります
HSC004 RSDアールアンドディー システムス
R&D Systems, Inc.
1 set ¥87,000
(未発注)
追加

在庫・価格 : 2024年04月28日 07時28分 現在

Methylcellulose Complete Media w/o Epo, for Human

  • 商品コード:HSC004
  • メーカー:RSD
  • 包装:1set
  • 価格: ¥87,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Doepfner KT et al. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Leukemia 2007 Sep;21(9):1921-30
Doepfner KT et al
2007/01/01
Species: Human, Application: Whole Cells PubMed
2 Zibara K et al. Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models. PLoS ONE 2012;7(7):e40140
Zibara K et al
2012/01/01
Sample Type: Whole Cells PubMed
3 Blackwood E et al. Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900. Mol. Cancer Ther. 2013 Oct;12(10):1968-80
Blackwood E et al
2013/01/01
Sample Type: whole cells PubMed
4 Fulciniti M et al. miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth. Blood Cancer J 2016;6:e380
Fulciniti M et al
2016/01/01
Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Doepfner KT et al. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Leukemia 2007 Sep;21(9):1921-30
    Doepfner KT et al
    2007/01/01
  • 備考:
    Species: Human, Application: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zibara K et al. Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models. PLoS ONE 2012;7(7):e40140
    Zibara K et al
    2012/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Blackwood E et al. Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900. Mol. Cancer Ther. 2013 Oct;12(10):1968-80
    Blackwood E et al
    2013/01/01
  • 備考:
    Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fulciniti M et al. miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth. Blood Cancer J 2016;6:e380
    Fulciniti M et al
    2016/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed